Establishment of biobanking facility at Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan

Author(s):  
Kashif Asghar ◽  
Asif Loya
Author(s):  
Manjunath K. ◽  
Amardeep Singh ◽  
Manjunatha Rao S. V.

<p class="abstract"><strong>Background:</strong> The aim of this study was to determine the frequency of otomycosis, the clinical presentation, predisposing factors and treatment outcome.</p><p class="abstract"><strong>Methods:</strong> This observational study was conducted at ENT Department of Basaveshwara Medical College and Hospital, Research centre, Chitradurga from May 2018 to June 2019, 13 months study. There were 50 patients with documented diagnosis of otomycosis. There were 19 (38%) males and 31 (62%) females. The age of patients ranged from 3 years to 65 years with mean age of 32.5 years. Mean follow-up time was 1 year (~13 months). The frequency, predisposing factors and most common symptoms of otomycosis were recorded along with the response to different Antifungal agents were observed and results were recorded in percentages. Data were analysed using SPSS 12 software. Results are based on descriptive statistics.  </p><p class="abstract"><strong>Results:</strong> We prescribed 1% clotrimazole drops or lotion in 58% of patients and 2% salicylic acid in 31% cases. Both of these agents are effective. Topical 1% clotrimazole drops yielded highest resolution rate with lowest recurrent rate. To analyse the efficacy of 1% clotrimazole and 2% salicylic acid. We applied Z-test to calculate the difference between two proportions of patients before treatment with those patients who remained uncured after treatment.</p><p class="abstract"><strong>Conclusions:</strong> Otomycosis commonly prevented with hearing loss, pruritus, otalgia and otorrhoea. It usually resolves with local toilet of ear and installation of antifungal agents.</p>


2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Asif Loya

SARS-CoV 2 (COVID-19) pandemic continues to have a debilitating effect on health worldwide. This editorial provides an overview of the provision of cancer services at Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, and Peshawar. 


2021 ◽  
pp. 1-13
Author(s):  
Julia Drake ◽  
Melissa Walker ◽  
Noelle Gallant ◽  
Emma Sturgess ◽  
Katie McGill

2018 ◽  
Vol 3 (4) ◽  
Author(s):  
Suhaib Bin Bilal Hafi ◽  
Nasira Hayat ◽  
Nosheen Qureshi ◽  
Tanzila Tanzeem ◽  
Sheheryar Jovindah ◽  
...  

Purpose: Screening for depression and anxiety for inpatients at Shaukat Khanum Memorial Cancer Hospital and Research Centre is done by nursing team by asking patients two questions from a structured admission tool aimed toward depression and anxiety. We audited the use of the current method of screening for depression and anxiety against standard screening tools for depression and anxiety i.e., Patient Health Questionnaire (PHQ)-9 and Generalised AnxietyDisorder (GAD)-7. The aim was improvement of screening for depression and anxiety amongst cancer inpatients.Methods: We used a cross-sectional method to observe if the current screening method was being completed on admission on an inpatient ward of 40 patients on one particular day. Second, we delivered PHQ-9 and GAD-7 as screening tools on the same inpatients on the same day to compare with the current screening method.Results: Prevalence of depression was 54.5% (n = 18) and that of generalized anxiety was 36.4% (n = 12), regardless of severity, when using PHQ-9 and GAD-7. Comparatively, the current method of screening was able to pick up 16.6% (n = 3) of cases of depression and 16.6% (n = 2) of cases of generalised anxiety.Conclusion: We concluded that improvement was required in the screening process for depression and anxiety by devising a new screening tool specific to our cancer population.Key words: Anxiety, cancer, depression, screening


Sign in / Sign up

Export Citation Format

Share Document